Biocatalytic synthesis of alkoxylated phenazine derivatives using methyltransferases

BACKGROUND: Phenazines are important nitrogen-containing heterocycles with diverse applications in the chemical and pharmaceutical industry. Alkoxylated phenazines, in particular, exhibit promising acaricidal and fungicidal properties. Currently, chemical synthesis is the main approach for alkoxylated phenazines and derivatives production. However, these processes are associated with harsh reaction conditions, accumulation of chemical waste (e.g., organic solvents, noble metal catalysts), and environmental concerns. RESULTS: In this study, we developed biocatalytic systems for the synthesis of alkoxylated phenazines by designing enzymatic systems and de novo biosynthetic pathways. The O-methyltransferase LaphzM from Lysobacter antibioticus OH13 was shown to catalyze the alkoxylation of phenazines using SAM analogs generated in situ by halide methyltransferases (HMTs) from Burkholderia xenovorans and Arabidopsis thaliana. Using these enzymatic systems, we successfully synthesized six alkoxylated phenazine derivatives, including three novel compounds. We further established de novo biosynthetic pathways for 1-ethoxyphenazine and 2-ethoxyphenazine in Pseudomonas chlororaphis via the direct sulfurylation pathway from S. cerevisiae. To improve production, we optimized whole-cell systems, achieving 486.3 mg/L (54% yield) of 2-ethoxyphenazine, 218.1 mg/L (22.8% yield) of 2-propoxyphenazine and 378.2 mg/L (78.4% yield) of 1-ethoxyphenazine-N'10-oxide within 7 h using microbially produced 2-hydroxyphenazine (for 2-ethoxyphenazine and 2-propoxyphenazine) or 1-hydroxyphenazine (for 1-ethoxyphenazine-N'10-oxide) as the substrate, along with ethyl iodide (EtI) or propyl iodide (PrI) accordingly. CONCLUSIONS: Overall, we successfully established biocatalytic platforms for alkoxylated phenazines through enzymatic catalysis and de novo biosynthetic pathways. Methyltransferases derived from diverse species, including LaphzM and HMTs, play key roles in the SAM-analog-mediated alkylation of phenazines. This study provides a promising alternative to conventional chemical synthesis, with significant potential for the manufacturing of alkoxylated phenazine derivatives.

Authors

Institutions

Publication Details

Journal
Microbial Cell Factories
Published
2026-07-17
DOI
https://doi.org/10.1186/s12934-026-03069-9
Primary Topic
Plant Gene Expression Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biocatalytic synthesis of alkoxylated phenazine derivatives using methyltransferases

Mohd Sadeeq, Sijia Xu, Chaozhi Wang, Yupeng Wan et al.
Microbial Cell Factories
Plant Gene Expression Analysis
article

Biocatalytic synthesis of alkoxylated phenazine derivatives using methyltransferases

Mohd Sadeeq, Sijia Xu, Chaozhi Wang, Yupeng Wan, Zhe Zhang, Shuo Zhang, Chen Gao, Chuanzeng Wang, Wei Huang, Feifei Hou, Peng Xiong
article en

Abstract

BACKGROUND: Phenazines are important nitrogen-containing heterocycles with diverse applications in the chemical and pharmaceutical industry. Alkoxylated phenazines, in particular, exhibit promising acaricidal and fungicidal properties. Currently, chemical synthesis is the main approach for alkoxylated phenazines and derivatives production. However, these processes are associated with harsh reaction conditions, accumulation of chemical waste (e.g., organic solvents, noble metal catalysts), and environmental concerns. RESULTS: In this study, we developed biocatalytic systems for the synthesis of alkoxylated phenazines by designing enzymatic systems and de novo biosynthetic pathways. The O-methyltransferase LaphzM from Lysobacter antibioticus OH13 was shown to catalyze the alkoxylation of phenazines using SAM analogs generated in situ by halide methyltransferases (HMTs) from Burkholderia xenovorans and Arabidopsis thaliana. Using these enzymatic systems, we successfully synthesized six alkoxylated phenazine derivatives, including three novel compounds. We further established de novo biosynthetic pathways for 1-ethoxyphenazine and 2-ethoxyphenazine in Pseudomonas chlororaphis via the direct sulfurylation pathway from S. cerevisiae. To improve production, we optimized whole-cell systems, achieving 486.3 mg/L (54% yield) of 2-ethoxyphenazine, 218.1 mg/L (22.8% yield) of 2-propoxyphenazine and 378.2 mg/L (78.4% yield) of 1-ethoxyphenazine-N'10-oxide within 7 h using microbially produced 2-hydroxyphenazine (for 2-ethoxyphenazine and 2-propoxyphenazine) or 1-hydroxyphenazine (for 1-ethoxyphenazine-N'10-oxide) as the substrate, along with ethyl iodide (EtI) or propyl iodide (PrI) accordingly. CONCLUSIONS: Overall, we successfully established biocatalytic platforms for alkoxylated phenazines through enzymatic catalysis and de novo biosynthetic pathways. Methyltransferases derived from diverse species, including LaphzM and HMTs, play key roles in the SAM-analog-mediated alkylation of phenazines. This study provides a promising alternative to conventional chemical synthesis, with significant potential for the manufacturing of alkoxylated phenazine derivatives.

Microbial Cell Factories
Shandong University of Technology (CN), Shandong University of Traditional Chinese Medicine (CN), Chinese Academy of Sciences (CN), Jinan Central Hospital (CN), Kai Biotech (South Korea) (KR), Qingdao Institute of Bioenergy and Bioprocess Technology (CN), Viva Biotech (China) (CN)
Industry, innovation and infrastructure
Openalex Percentile: Top 14%
Plant Gene Expression Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.